Sign in
An Analysis of Particle Contamination and Protein Aggregation From Syringes Used for Intravitreal Injection
Jason Noble, MD, FRCSC
On Demand Cases, Courses, and Papers
2021
Baseline Factors Associated With 1-Year Outcomes in Phase III Comparison of SB11 (Approved Ranibizumab Biosimilar) With Reference Ranibizumab in nAMD
Neil M. Bressler, MD
Annual Meeting Talks
2022
Barriers to Follow-up Retinal Care During the COVID-19 Pandemic: A Survey Study
Michael A Klufas, MD
Category: Risk Management